Dasatinib has been evaluated in numerous clinical trials spanning Phase 1 through Phase 4 to assess its efficacy across oncological, infectious, and neurodegenerative indications, including acute lymphoblastic leukemia, acute myelogenous leukemia, metastatic triple-negative breast cancer, metastatic prostate cancer, primary HIV-1 infection, and Alzheimer's disease. Sponsored by academic centers such as Stanford University, national entities like the National Cancer Institute, and clinical research networks, these studies encompass recruitment statuses ranging from actively recruiting and completed to terminated or active, not recruiting.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT02689440 | ACTIVE_NOT_RECRUITING | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia |
M.D. Anderson Cancer Center |
2016-02-19 | PHASE2 |
| NCT05725200 | RECRUITING | Metastatic Colorectal Cancer |
Oslo University Hospital |
2022-09-27 | PHASE2 |
| NCT07493408 | NOT_YET_RECRUITING | Ph+ Acute Lymphoblastic Leukemia (Ph+ALL); Blastic Transformation of Chronic Myeloid Leukemia; Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL); Haematopoietic Stem Cell Transplant, Allogeneic |
The University of Hong Kong |
2026-03-30 | PHASE2 |
| NCT06257394 | RECRUITING | Acute Lymphoblastic Leukemia, Pediatric |
Hyoung Jin Kang |
2024-10-20 | PHASE2 |
| NCT05751044 | RECRUITING | Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent; Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent; Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory; Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory |
Princess Maxima Center for Pediatric Oncology |
2025-10-01 | PHASE1; PHASE2 |
| NCT06940297 | RECRUITING | Recurrent Multiple Myeloma; Refractory Multiple Myeloma |
Mayo Clinic |
2025-09-18 | PHASE2 |
| NCT01746836 | RECRUITING | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive |
M.D. Anderson Cancer Center |
2013-01-17 | PHASE2 |
| NCT07804901 | NOT_YET_RECRUITING | Chronic Myeloid Leukemia (CML) |
Prof. Dr. med. Andreas Hochhaus |
2027-01-01 | PHASE2 |
| NCT06124157 | RECRUITING | B Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2025-05-30 | PHASE2 |
| NCT02559778 | RECRUITING | Neuroblastoma |
Giselle Sholler |
2015-09 | PHASE2 |
| NCT04877522 | RECRUITING | Chronic Myelogenous Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
Novartis Pharmaceuticals |
2022-08-30 | PHASE4 |
| NCT06855810 | RECRUITING | Acute Lymphoblastic Leukemia; Childhood Leukemia, Acute Lymphoblastic; T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma |
Institute of Hematology & Blood Diseases Hospital, China |
2025-03-11 | PHASE2; PHASE3 |
| NCT06336395 | RECRUITING | B Lymphoblastic Leukemia |
National University Hospital, Singapore |
2020-03-04 | PHASE2 |
| NCT07269470 | RECRUITING | Chronic Myeloid Leukemia |
M.D. Anderson Cancer Center |
2026-07-13 | PHASE2 |
| NCT06773936 | ENROLLING_BY_INVITATION | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia; CD19+ Acute Leukemia |
SWOG Cancer Research Network |
2026-04-13 | PHASE2 |
| NCT04626024 | ACTIVE_NOT_RECRUITING | Chronic Myeloid Leukemia; Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission; Chronic Myeloid Leukemia in Remission |
Baylor College of Medicine |
2020-12-22 | PHASE2 |
| NCT03516279 | ACTIVE_NOT_RECRUITING | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Minimal Residual Disease |
ECOG-ACRIN Cancer Research Group |
2019-06-26 | PHASE2 |
| NCT04530565 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 |
National Cancer Institute (NCI) |
2021-01-25 | PHASE3 |
| NCT04838041 | RECRUITING | Chronic Phase Chronic Myelogenous Leukemia |
Medical College of Wisconsin |
2021-11-11 | PHASE2 |
| NCT07046182 | ACTIVE_NOT_RECRUITING | Angioimmunoblastic T-cell Lymphoma (AITL) |
Zhengzhou University |
2023-10-21 | PHASE4 |
| NCT06533748 | RECRUITING | Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma |
St. Jude Children's Research Hospital |
2025-01-23 | PHASE2 |
| NCT07538401 | NOT_YET_RECRUITING | Chronic Myeloid Leukemia (CML) in |
University Health Network, Toronto |
2026-04-25 | PHASE2 |
| NCT04747912 | RECRUITING | Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia; ph+ Acute Lymphoblastic Leukemia |
University of Chicago |
2021-03-02 | PHASE2 |
| NCT04685590 | ACTIVE_NOT_RECRUITING | Alzheimer Disease, Early Onset; Mild Cognitive Impairment |
Washington University School of Medicine |
2021-12-22 | PHASE2 |
| NCT04872790 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Mixed Phenotype Acute Leukemia; Recurrent B Acute Lymphoblastic Leukemia; Recurrent Mixed Phenotype Acute Leukemia |
OHSU Knight Cancer Institute |
2022-09-02 | PHASE1 |
| NCT06390319 | RECRUITING | T-cell Acute Lymphoblastic Leukemia; T-cell Lymphoma; Mixed Phenotype Acute Leukemia |
St. Jude Children's Research Hospital |
2024-12-27 | PHASE2 |
| NCT02389309 | ACTIVE_NOT_RECRUITING | Advanced Malignant Solid Neoplasm; Recurrent Brain Neoplasm; Recurrent Malignant Solid Neoplasm; Refractory Brain Neoplasm |
M.D. Anderson Cancer Center |
2015-10-05 | PHASE1 |
| NCT05838560 | ACTIVE_NOT_RECRUITING | Schizophrenia; Treatment Resistant Depression; Aging, Premature |
Washington University School of Medicine |
2023-07-01 | PHASE2 |
| NCT07025226 | RECRUITING | Glioma |
Mayo Clinic |
2025-08-12 | EARLY_PHASE1 |
| NCT05432518 | RECRUITING | Glioblastoma; Recurrent Disease; Recurrent Glioblastoma |
AHS Cancer Control Alberta |
2023-06-27 | EARLY_PHASE1 |
| NCT02494882 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia |
Memorial Sloan Kettering Cancer Center |
2015-06-29 | PHASE1 |
| NCT05993949 | ACTIVE_NOT_RECRUITING | Lymphoblastic Leukemia |
Stanford University |
2023-10-02 | PHASE1 |
| NCT05036226 | RECRUITING | Prostate Cancer Recurrent; Solid Tumor, Adult |
Medical University of South Carolina |
2022-03-03 | PHASE1; PHASE2 |
| NCT02848131 | ENROLLING_BY_INVITATION | Chronic Kidney Disease |
Mayo Clinic |
2016-07 | PHASE2 |
| NCT04329325 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Philadelphia Chromosome-Positive |
Memorial Sloan Kettering Cancer Center |
2020-03-30 | PHASE2 |
| NCT06645886 | ACTIVE_NOT_RECRUITING | Hematologic Malignancies; Adult |
Kumquat Biosciences Inc. |
2024-12-09 | PHASE1 |
| NCT03906292 | ACTIVE_NOT_RECRUITING | Chronic Myeloid Leukemia |
University of Jena |
2019-08-19 | PHASE2 |
| NCT05653258 | RECRUITING | Obesity; Healthy Lifestyle |
Cedars-Sinai Medical Center |
2023-10-17 | PHASE2; PHASE3 |
| NCT07270120 | NOT_YET_RECRUITING | Multiple Sclerosis (MS) Secondary Progressive |
Ohio State University |
2026-01-15 | PHASE1 |
| NCT03297606 | RECRUITING | Lymphoma, Non-Hodgkin; Multiple Myeloma; Advanced Solid Tumors |
Canadian Cancer Trials Group |
2018-03-23 | PHASE2 |
| NCT02465060 | ACTIVE_NOT_RECRUITING | Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Bladder Carcinoma; Breast Carcinoma; Cervical Carcinoma; Colon Carcinoma; Colorectal Carcinoma; Endometrial Carcinoma; Esophageal Carcinoma; Exocrine Pancreas Carcinoma; Gastric Carcinoma; Glioma; Head and Neck Carcinoma; Hematopoietic and Lymphoid Cell Neoplasm; Kidney Carcinoma; Liver Carcinoma; Lung Carcinoma; Lymphoma; Malignant Uterine Corpus Neoplasm; Malignant Uterine Neoplasm; Melanoma; Multiple Myeloma; Ovarian Carcinoma; Prostate Carcinoma; Rectal Carcinoma; Recurrent Bladder Carcinoma; Recurrent Breast Carcinoma; Recurrent Cervical Carcinoma; Recurrent Colon Carcinoma; Recurrent Colorectal Carcinoma; Recurrent Esophageal Carcinoma; Recurrent Gastric Carcinoma; Recurrent Glioma; Recurrent Head and Neck Carcinoma; Recurrent Liver Carcinoma; Recurrent Lung Carcinoma; Recurrent Lymphoma; Recurrent Malignant Solid Neoplasm; Recurrent Malignant Uterine Corpus Neoplasm; Recurrent Melanoma; Recurrent Multiple Myeloma; Recurrent Ovarian Carcinoma; Recurrent Pancreatic Carcinoma; Recurrent Prostate Carcinoma; Recurrent Rectal Carcinoma; Recurrent Skin Carcinoma; Recurrent Thyroid Gland Carcinoma; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Multiple Myeloma; Skin Carcinoma; Thyroid Gland Carcinoma |
National Cancer Institute (NCI) |
2015-08-17 | PHASE2 |
| NCT04733534 | ACTIVE_NOT_RECRUITING | Frailty; Childhood Cancer |
St. Jude Children's Research Hospital |
2022-06-06 | PHASE2 |
| NCT04785300 | ACTIVE_NOT_RECRUITING | Mild Cognitive Impairment; Alzheimer Disease |
Mayo Clinic |
2022-07-06 | PHASE1; PHASE2 |
| NCT05527418 | ACTIVE_NOT_RECRUITING | Recent HIV-1 Infection |
Eva Bonfill |
2024-01-26 | PHASE2 |
| NCT03020030 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia, Pediatric |
Dana-Farber Cancer Institute |
2017-03-03 | PHASE3 |
| NCT07342491 | RECRUITING | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
2026-05-08 | PHASE1 |
| NCT03595917 | RECRUITING | B-cell Acute Lymphoblastic Leukemia; Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis; Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL |
Marlise Luskin, MD |
2018-07-24 | PHASE1 |
| NCT05007873 | ACTIVE_NOT_RECRUITING | Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive; BCR-ABL1 Positive Chronic Myelogenous Leukemia; BCR-ABL1 Positive |
M.D. Anderson Cancer Center |
2021-10-21 | PHASE2 |
| NCT03117751 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma |
St. Jude Children's Research Hospital |
2017-03-29 | PHASE2; PHASE3 |
| NCT07144293 | ACTIVE_NOT_RECRUITING | HIV; Frailty; Prefrail; Aging Problems |
National Institute of Allergy and Infectious Diseases (NIAID) |
2025-12-04 | PHASE2 |
| NCT06055621 | RECRUITING | Acute Myeloid Leukemia |
Institut Paoli-Calmettes |
2024-05-22 | PHASE2 |
| NCT04147533 | ACTIVE_NOT_RECRUITING | Chronic Myeloid Leukemia, Chronic Phase; Withdrawal;Drug |
Masaryk University |
2020-06-16 | PHASE2 |
| NCT07000734 | COMPLETED | Aging; Cognitive Decline; Older Adults; Cardiovascular; Sedentary Behaviors; Immune Senescence; Motor Function |
Washington University School of Medicine |
2025-07-28 | PHASE2 |
| NCT06018467 | ACTIVE_NOT_RECRUITING | Osteopenia, Osteoporosis; Age-related Bone Loss |
Odense University Hospital |
2023-09-06 | PHASE2 |
| NCT05506488 | COMPLETED | NAFLD; NASH With Fibrosis; Liver Fibrosis |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2023-07-05 | PHASE1; PHASE2 |
| NCT05751733 | RECRUITING | Gastrointestinal Stromal Tumors |
Xiangya Hospital of Central South University |
2023-02-01 | |
| NCT04845035 | WITHDRAWN | Acute Lymphoblastic Leukemia |
University of Michigan Rogel Cancer Center |
2024-01 | PHASE2 |
| NCT03193281 | UNKNOWN | Chronic Myeloid Leukemia |
University of Auckland, New Zealand |
2017-07-17 | PHASE2 |
| NCT03844360 | RECRUITING | Hematological Neoplasms |
Wei Zhao |
2016-01-31 | PHASE4 |
| NCT05944783 | NOT_YET_RECRUITING | Myeloma Multiple |
Centro de Atencion e Investigacion Medica |
2025-09-01 | PHASE4 |
| NCT04925648 | COMPLETED | Metastatic Prostate Cancer |
St Vincent's Hospital, Sydney |
2021-10-18 | PHASE2 |
| NCT05780073 | COMPLETED | HIV Infection Primary |
Fundació Institut Germans Trias i Pujol |
2023-10-16 | PHASE2 |
| NCT00254423 | COMPLETED | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia |
M.D. Anderson Cancer Center |
2005-11-08 | PHASE2 |
| NCT05523661 | UNKNOWN | Ph Positive ALL; CAR-T Cell; Dasatinib |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2021-03-01 | PHASE1 |
| NCT04578847 | UNKNOWN | Chronic Myeloid Leukemia; Chronic Myeloid Leukemia in Remission; BCR-ABL Positive Chronic Myelogenous Leukemia |
National Research Center for Hematology, Russia |
2020-01-15 | PHASE2 |
| NCT06355037 | UNKNOWN | Triple-negative Breast Cancer |
Fudan University |
2024-05-20 | PHASE2 |
| NCT04835584 | UNKNOWN | Chronic Myeloid Leukemia |
Kartos Therapeutics, Inc. |
2021-05-07 | PHASE1; PHASE2 |
| NCT03173612 | UNKNOWN | Acute Myeloid Leukemia |
Institute of Hematology & Blood Diseases Hospital, China |
2016-08 | |
| NCT05638763 | UNKNOWN | Chronic Myeloid Leukemia, Chronic Phase |
Hospital Universitario Dr. Jose E. Gonzalez |
2024-11 | PHASE2 |
| NCT01990196 | ACTIVE_NOT_RECRUITING | Prostate Cancer |
Jonsson Comprehensive Cancer Center |
2014-09-23 | PHASE2 |
| NCT04126681 | COMPLETED | Chronic Myeloid Leukemia, Chronic Phase |
Ascentage Pharma Group Inc. |
2019-10-21 | PHASE2 |
| NCT03654768 | ACTIVE_NOT_RECRUITING | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive |
SWOG Cancer Research Network |
2018-10-24 | PHASE2 |
| NCT05192889 | ACTIVE_NOT_RECRUITING | Refractory Acute Lymphoblastic Leukemia; Relapsed Acute Lymphoblastic Leukemia |
St. Jude Children's Research Hospital |
2022-08-25 | PHASE1; PHASE2 |
| NCT05724329 | ACTIVE_NOT_RECRUITING | Head and Neck Squamous Cell Carcinomas |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2023-02-05 | PHASE2 |
| NCT05559008 | UNKNOWN | Peripheral T Cell Lymphoma |
Ruijin Hospital |
2022-09-30 | PHASE1; PHASE2 |
| NCT00390793 | COMPLETED | Acute Lymphoblastic Leukemia; BCR-ABL1 Fusion Protein Expression; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Recurrent Acute Lymphoblastic Leukemia; t(9;22) |
M.D. Anderson Cancer Center |
2006-09-28 | PHASE2 |
| NCT02013648 | COMPLETED | Acute Myeloid Leukemia (AML) |
University of Ulm |
2014-07 | PHASE3 |
| NCT01471106 | COMPLETED | Breast Cancer |
M.D. Anderson Cancer Center |
2014-01-21 | PHASE2 |
| NCT05422885 | COMPLETED | Aging |
Lewis Lipsitz |
2022-05-20 | PHASE1; PHASE2 |
| NCT05527418 | Recruiting | Recent HIV-1 Infection |
Eva Bonfill|Institut d''Investigacions Biomèdiques August Pi i Sunyer |
2024-01-26 | Phase 2 |
| NCT02326311 | COMPLETED | Leukemia, Chronic Myeloid |
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
2015-06-10 | PHASE3 |
| NCT05198843 | TERMINATED | Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Triple-Negative Breast Inflammatory Carcinoma |
National Cancer Institute (NCI) |
2022-11-08 | PHASE1; PHASE2 |
| NCT04830735 | WITHDRAWN | Symptomatic COVID-19 Infection Laboratory-Confirmed |
University of Southern California |
2022-08-05 | PHASE2 |
| NCT01254864 | COMPLETED | Prostate Cancer |
M.D. Anderson Cancer Center |
2011-03-16 | PHASE2 |
| NCT04994561 | WITHDRAWN | Aging |
Vitality in Aging Research Group, Inc. |
2022-06 | PHASE1 |
| NCT04971226 | ACTIVE_NOT_RECRUITING | Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive |
Novartis Pharmaceuticals |
2021-10-06 | PHASE3 |
| NCT04603872 | RECRUITING | Multiple Myeloma in Relapse; Multiple Myeloma, Refractory; Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphocytic Leukaemia Refractory; Non-Hodgkin's Lymphoma, Relapsed; Non-Hodgkin's Lymphoma Refractory |
Zhejiang University |
2020-11-01 | EARLY_PHASE1 |
| NCT05993949 | Recruiting | Lymphoblastic Leukemia |
Stanford University|Kite Pharma |
2023-10-02 | Phase 1 |
| NCT05780073 | Recruiting | HIV Infection Primary |
Fundació Institut Germans Trias i Pujol|Fundación FLS de Lucha Contra el Sida Enfermedades Infecciosas y Promoción de la Salud y Ciencia|Spanish Clinical Research Network - SCReN|IrsiCaixa|University of Turin Italy|Instituto de Salud Carlos III|Germans Trias i Pujol Hospital |
2023-10-16 | Phase 2 |
| NCT05042531 | UNKNOWN | Acute Myeloid Leukemia |
LanZhou University |
2021-11-13 | |
| NCT03564470 | UNKNOWN | Leukemia; Leukemia, Acute; Leukemia, Lymphoblastic; Leukemia, B-cell |
Nanfang Hospital, Southern Medical University |
2016-02-14 | PHASE2; PHASE3 |
| NCT06145217 | COMPLETED | Drug-drug Interaction Study |
Xspray Pharma AB |
2023-08-22 | PHASE1 |
| NCT04580121 | COMPLETED | Acute Myeloid Leukemia |
Hoffmann-La Roche |
2020-11-04 | PHASE1 |
| NCT03625388 | COMPLETED | Chronic Myelogenous Leukemia |
Hikma Pharmaceuticals LLC |
2018-11-05 | PHASE2 |
| NCT05026229 | UNKNOWN | Precursor Cell Lymphoblastic Leukemia-Lymphoma; Philadelphia-Positive Acute Lymphoblastic Leukemia; ALL, Adult |
First Affiliated Hospital Xi'an Jiaotong University |
2021-09-06 | |
| NCT05024357 | UNKNOWN | Precursor Cell Lymphoblastic Leukemia-Lymphoma; Philadelphia-Positive Acute Lymphoblastic Leukemia; ALL, Adult |
First Affiliated Hospital Xi'an Jiaotong University |
2021-09-06 | |
| NCT04164069 | COMPLETED | Advanced Colorectal Carcinoma; Metastatic Colorectal Carcinoma; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8; Stage II Colon Cancer; Stage II Rectal Cancer; Stage III Colon Cancer; Stage III Rectal Cancer; Esophageal Cancer; Pancreatic Cancer; Bile Duct Cancer; Gastric Cancer; Gall Bladder Cancer; Small Bowel Adenocarcinoma |
Anne Noonan |
2020-09-02 | PHASE1 |
| NCT04313634 | COMPLETED | Healthy |
Sundeep Khosla, M.D. |
2020-06-09 | PHASE2 |
| NCT02652052 | COMPLETED | Stem Cell Transplant |
Mayo Clinic |
2016-03-01 | PHASE1 |
| NCT04933526 | UNKNOWN | Chronic Myeloid Leukemia in Chronic Phase |
Shenzhen Second People's Hospital |
2021-07-01 | PHASE4 |
| NCT02890784 | COMPLETED | Myeloid Leukemia, Chronic |
University of Jena |
2016-08 | PHASE3 |
| NCT03573596 | UNKNOWN | CML, Relapsed |
Amsterdam UMC, location VUmc |
2018-02-01 | PHASE2 |
| NCT02883049 | COMPLETED | B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, BCR-ABL1-Like; Central Nervous System Leukemia; Testicular Leukemia |
National Cancer Institute (NCI) |
2012-02-29 | PHASE3 |
| NCT04155411 | UNKNOWN | Dasatinib; BCR-ABL; Chronic Myeloid Leukemia |
Shenzhen Second People's Hospital |
2019-12-01 | PHASE4 |
| NCT05198843 | Terminated | Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Triple-Negative Breast Inflammatory Carcinoma |
National Cancer Institute (NCI) |
2022-11-08 | Phase 1|Phase 2 |
| NCT00652574 | COMPLETED | Malignant Pleural Mesothelioma |
M.D. Anderson Cancer Center |
2008-03-12 | PHASE1 |
| NCT02143414 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Recurrent Acute Lymphoblastic Leukemia; Refractory Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2015-06-30 | PHASE2 |
| NCT02297139 | COMPLETED | Multiple Indications Cancer |
Bristol-Myers Squibb |
2015-07-31 | PHASE2 |
| NCT02043587 | TERMINATED | Acute Lymphocytic Leukemia; Adult Lymphoblastic Lymphoma |
University of California, San Diego |
2014-01 | PHASE2 |
| NCT03414450 | WITHDRAWN | Ph+ Acute Lymphoblastic Leukemia (Ph+ALL); Ph- Acute Lymphoblastic Leukemia (Ph-ALL); Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+); Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+) |
EDDC (Experimental Drug Development Centre), A*STAR Research Entities |
2018-04-25 | PHASE1 |
| NCT02523976 | COMPLETED | Acute,Leukemia, Lymphoid |
Institute of Hematology & Blood Diseases Hospital, China |
2015-08-01 | PHASE2 |
| NCT04115059 | TERMINATED | Waldenstrom Macroglobulinemia; DASATINIB |
Jorge J. Castillo, MD |
2019-11-04 | PHASE1 |
| NCT04946383 | UNKNOWN | Aging |
TruDiagnostic |
2020-12-16 | PHASE2 |
| NCT04063124 | COMPLETED | Alzheimer Disease |
The University of Texas Health Science Center at San Antonio |
2020-02-14 | PHASE1; PHASE2 |
| NCT02638428 | UNKNOWN | Relapsed Pediatric Solid Tumor; Refractory Pediatric Solid Tumor; Relapsed Pediatric AML; Refractory Pediatric AML |
Samsung Medical Center |
2015-12 | PHASE2 |
| NCT04925648 | Recruiting | Metastatic Prostate Cancer |
St Vincent''s Hospital Sydney |
2021-10-18 | Phase 2 |
| NCT03041701 | TERMINATED | Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal |
National Cancer Institute (NCI) |
2017-07-07 | PHASE1; PHASE2 |
| NCT05439408 | COMPLETED | Biological Availability |
Xspray Pharma AB |
2021-06-07 | PHASE1 |
| NCT02081378 | COMPLETED | Chronic Myelogenous Leukemia; Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia |
Novartis Pharmaceuticals |
2014-04-24 | PHASE1 |
| NCT02744768 | UNKNOWN | Acute Lymphoblastic Leukemia |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2017-05-31 | PHASE2 |
| NCT01015222 | COMPLETED | Advanced Cancer |
M.D. Anderson Cancer Center |
2009-11 | PHASE1 |
| NCT03023046 | COMPLETED | Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma |
University of Washington |
2017-02-23 | PHASE2 |
| NCT02269267 | COMPLETED | Leukemia, Myeloid, Chronic |
Medical College of Wisconsin |
2014-12-18 | PHASE2 |
| NCT02596828 | COMPLETED | Pineoblastoma |
University of Regensburg |
2016-04 | PHASE2 |
| NCT02420717 | TERMINATED | Recurrent B Acute Lymphoblastic Leukemia; Recurrent Ph-Like Acute Lymphoblastic Leukemia; Refractory B Acute Lymphoblastic Leukemia; Refractory Ph-Like Acute Lymphoblastic Leukemia |
M.D. Anderson Cancer Center |
2015-07-15 | PHASE2 |
| NCT03560908 | WITHDRAWN | Relapsed AML; T(8;21); C-KIT Mutation |
Institute of Hematology & Blood Diseases Hospital, China |
2018-07-01 | PHASE1 |
| NCT04284202 | UNKNOWN | NSCLC Stage IV; ARID1A; PD-1 |
The Affiliated Hospital of Qingdao University |
2020-03-01 | PHASE2 |
| NCT05433896 | COMPLETED | Pharmacokinetics; Drug Interactions |
Xspray Pharma AB |
2020-11-01 | PHASE1 |
| NCT03878524 | TERMINATED | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Anatomic Stage IV Breast Cancer AJCC v8; Anemia; Ann Arbor Stage III Hodgkin Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Castration-Resistant Prostate Carcinoma; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Hematopoietic and Lymphoid System Neoplasm; Locally Advanced Pancreatic Adenocarcinoma; Metastatic Breast Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Pancreatic Adenocarcinoma; Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Primary Myelofibrosis; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Hematologic Malignancy; Recurrent Hodgkin Lymphoma; Recurrent Myelodysplastic Syndrome; Recurrent Myelodysplastic/Myeloproliferative Neoplasm; Recurrent Myeloproliferative Neoplasm; Recurrent Non-Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Refractory Chronic Myelomonocytic Leukemia; Refractory Hematologic Malignancy; Refractory Hodgkin Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Myelodysplastic Syndrome; Refractory Myelodysplastic/Myeloproliferative Neoplasm; Refractory Non-Hodgkin Lymphoma; Refractory Plasma Cell Myeloma; Refractory Primary Myelofibrosis; Refractory Small Lymphocytic Lymphoma; Stage II Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8; Unresectable Pancreatic Adenocarcinoma |
OHSU Knight Cancer Institute |
2020-04-01 | PHASE1 |
| NCT00566618 | COMPLETED | Breast Cancer; Bone Metastases |
M.D. Anderson Cancer Center |
2007-11-01 | PHASE1; PHASE2 |
| NCT02268370 | UNKNOWN | Chronic Myeloid Leukemia |
University Health Network, Toronto |
2014-10 | PHASE2 |
| NCT01467986 | COMPLETED | Neuroblastoma Recurrent |
University of Regensburg |
2013-08 | PHASE2 |
| NCT00549848 | COMPLETED | Acute Lymphoblastic Leukemia |
St. Jude Children's Research Hospital |
2007-10-29 | PHASE3 |
| NCT03515200 | TERMINATED | Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia With Failed Remission |
St. Jude Children's Research Hospital |
2018-04-20 | PHASE1 |
| NCT02720185 | TERMINATED | Breast Neoplasms; Triple Negative Breast Neoplasms |
University of Wisconsin, Madison |
2017-05-03 | PHASE2 |
| NCT02923986 | WITHDRAWN | Chronic Myelogenous Leukemia, Ph1-Positive; Acute Myeloid Leukemia; Myelodysplastic Syndrome |
Bio-Path Holdings, Inc. |
2017-09-01 | PHASE1; PHASE2 |
| NCT01916135 | COMPLETED | Carcinoma; Sarcoma; Myeloma; Lymphoma; Melanoma |
Memorial Sloan Kettering Cancer Center |
2013-07 | PHASE1 |
| NCT02750514 | TERMINATED | Advanced Cancer |
Bristol-Myers Squibb |
2016-05-09 | PHASE2 |
| NCT03205267 | UNKNOWN | Chronic Myelogenous Leukaemia |
University of Bonn |
2016-03 | PHASE2 |
| NCT01751425 | TERMINATED | Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission; Minimal Residual Disease; Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia |
M.D. Anderson Cancer Center |
2013-07-24 | PHASE1 |
| NCT01498445 | TERMINATED | Leukemia |
M.D. Anderson Cancer Center |
2012-06-12 | PHASE1; PHASE2 |
| NCT02874989 | COMPLETED | Idiopathic Pulmonary Fibrosis (IPF) |
Wake Forest University Health Sciences |
2016-12-16 | PHASE1 |
| NCT03352427 | TERMINATED | Glioma; High Grade Glioma; Pontine Tumors |
University of Michigan Rogel Cancer Center |
2017-12-06 | PHASE2 |
| NCT01744652 | COMPLETED | Advanced Cancers |
M.D. Anderson Cancer Center |
2013-03 | PHASE1 |
| NCT02011945 | COMPLETED | Chronic Myeloid Leukemia |
Bristol-Myers Squibb |
2014-02-07 | PHASE1 |
| NCT01872442 | COMPLETED | Chronic Phase of Chronic Myeloid Leukemia |
Poitiers University Hospital |
2013-10-15 | PHASE2 |
| NCT04925141 | COMPLETED | Chronic Myelogenous Leukemia - Chronic Phase |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2016-05-10 | PHASE4 |
| NCT01609816 | TERMINATED | Non-Hodgkin's Lymphoma; Multiple; Mycosis Fungoides; Hodgkin's Lymphoma; Multiple Myeloma |
Barbara Ann Karmanos Cancer Institute |
2015-02-12 | PHASE1 |
| NCT01643603 | TERMINATED | Non-Hodgkin's Lymphoma; Hodgkin's Lymphoma; Myeloid Leukemia; Multiple Myeloma; Myelodysplastic Syndrome; Lymphoid Leukemia |
Barbara Ann Karmanos Cancer Institute |
2012-05 | PHASE1 |
| NCT05640804 | COMPLETED | Leukemia, Myelogenous, Chronic |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2018-09-09 | PHASE1 |
| NCT03216070 | UNKNOWN | Chronic Myelogenous Leukemia |
Hospital Universitario Dr. Jose E. Gonzalez |
2016-04-01 | PHASE4 |
| NCT02233049 | UNKNOWN | Diffuse Intrinsic Pontine Glioma |
Gustave Roussy, Cancer Campus, Grand Paris |
2014-10 | PHASE2 |
| NCT03079505 | TERMINATED | Chronic Myeloid Leukemia - Chronic Phase |
Hamad Medical Corporation |
2017-08-03 | PHASE3 |
| NCT01667133 | COMPLETED | Chronic Myeloid Leukemia (CML); Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) |
Ariad Pharmaceuticals |
2012-08-31 | PHASE1; PHASE2 |
| NCT00820170 | COMPLETED | Breast Cancer |
Memorial Sloan Kettering Cancer Center |
2009-01 | PHASE1; PHASE2 |
| NCT02954523 | TERMINATED | EGFR Gene Mutation; Nonsmall Cell Lung Cancer |
Chul Kim |
2016-10 | PHASE1; PHASE2 |
| NCT01876212 | COMPLETED | Metastatic Melanoma |
Walter J. Storkus |
2014-05-16 | PHASE2 |
| NCT02709083 | TERMINATED | Chronic Myelogenous Leukemia; Chronic Myeloid Leukemia; Leukemia |
Emory University |
2016-10 | PHASE2 |
| NCT04439305 | WITHDRAWN | Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Plasma Cell Myeloma |
National Cancer Institute (NCI) |
2016-02-25 | PHASE2 |
| NCT01804985 | COMPLETED | Chronic Myeloid Leukaemia |
University of Liverpool |
2013-12 | PHASE2 |
| NCT01876953 | TERMINATED | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Recurrent Adult Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid Leukemia |
City of Hope Medical Center |
2013-09-13 | PHASE1; PHASE2 |
| NCT02779283 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia |
OHSU Knight Cancer Institute |
2016-01-13 | PHASE1 |
| NCT01460693 | COMPLETED | Myeloid Leukemia, Chronic, Chronic Phase |
Newcastle University |
2008-08 | PHASE3 |
| NCT01644773 | COMPLETED | Diffuse Intrinsic Pontine Glioma; High-grade Glioma |
St. Jude Children's Research Hospital |
2012-11-27 | PHASE1 |
| NCT02428855 | COMPLETED | Cholangiocarcinoma |
Massachusetts General Hospital |
2015-04 | PHASE2 |
| NCT02389920 | UNKNOWN | Leukemia, Chronic Myeloid |
Samsung Medical Center |
2015-04 | PHASE4 |
| NCT01652976 | COMPLETED | Pancreatic Cancer Metastatic |
University of Florida |
2012-07 | PHASE2 |
| NCT02815059 | WITHDRAWN | Acute Lymphoblastic Leukemia |
University of Utah |
2016-09-28 | PHASE1 |
| NCT01636908 | COMPLETED | Cancer; Advanced Solid Tumors |
Amsterdam UMC, location VUmc |
2011-08 | |
| NCT01445509 | COMPLETED | Solid Tumors |
National Cancer Institute (NCI) |
2008-12-29 | PHASE1 |
| NCT02680951 | WITHDRAWN | Acute Myeloid Leukemia |
Emory University |
2015-12 | PHASE1 |
| NCT01234935 | COMPLETED | Acinar Cell Adenocarcinoma of the Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage IA Pancreatic Cancer; Stage IB Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer; Stage III Pancreatic Cancer |
Translational Oncology Research International |
2011-01-13 | PHASE2 |
| NCT01256398 | COMPLETED | Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 |
National Cancer Institute (NCI) |
2010-12-14 | PHASE2 |
| NCT01593254 | COMPLETED | Chronic Phase Chronic Myeloid Leukemia |
Bristol-Myers Squibb |
2012-09-12 | PHASE2 |
| NCT02776878 | UNKNOWN | Gastrointestinal Stromal Tumor |
Peking University Cancer Hospital & Institute |
2016-05 | |
| NCT01850004 | COMPLETED | Chronic Phase Chronic Myeloid Leukemia |
Bristol-Myers Squibb |
2014-01-22 | PHASE2 |
| NCT01660971 | ACTIVE_NOT_RECRUITING | Metastatic Pancreatic Adenocarcinoma; Recurrent Pancreatic Carcinoma; Stage III Pancreatic Cancer AJCC v6 and v7; Stage IV Pancreatic Cancer AJCC v6 and v7 |
National Cancer Institute (NCI) |
2012-07-30 | PHASE1 |
| NCT02819804 | TERMINATED | B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Refractory Childhood Acute Lymphoblastic Leukemia |
Northwestern University |
2017-08-17 | PHASE1 |
| NCT01460160 | COMPLETED | Leukemia, Pediatric |
Bristol-Myers Squibb |
2012-04-13 | PHASE2 |
| NCT01620216 | TERMINATED | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia |
OHSU Knight Cancer Institute |
2012-05-11 | PHASE2 |
| NCT01999985 | COMPLETED | Lung Cancer; Non-small Cell Lung Cancer (NSCLC) |
H. Lee Moffitt Cancer Center and Research Institute |
2013-12-31 | PHASE1 |
| NCT00255346 | COMPLETED | Acute Myeloid Leukemia; Myelodysplastic Syndromes; Agnogenic Myeloid Metaplasia; Myelofibrosis; Hypereosinophilic Syndrome; Polycythemia Vera; Mastocytosis; Leukemia, Myelomonocytic, Chronic |
M.D. Anderson Cancer Center |
2005-11-15 | PHASE2 |
| NCT00501410 | COMPLETED | Colorectal Cancer |
M.D. Anderson Cancer Center |
2007-04-23 | PHASE1 |
| NCT02059265 | TERMINATED | Endometrial Clear Cell Adenocarcinoma; Ovarian Clear Cell Cystadenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Uterine Corpus Cancer |
National Cancer Institute (NCI) |
2014-02-14 | PHASE2 |
| NCT01627132 | UNKNOWN | Chronic Myeloid Leukemia |
Shimousa Hematology Study Group |
2012-02 | PHASE2 |
| NCT02690922 | UNKNOWN | ph+ Acute Lymphoblastic Leukemia |
Tongji Hospital |
2016-03 | PHASE4 |
| NCT00464620 | COMPLETED | Rhabdomyosarcoma; Malignant Peripheral Nerve Sheath Tumors; Chondrosarcoma; Sarcoma, Ewing's; Sarcoma, Alveolar Soft Part; Chordoma; Epithelioid Sarcoma; Giant Cell Tumor of Bone; Hemangiopericytoma; Gastrointestinal Stromal Tumor (GIST) |
Sarcoma Alliance for Research through Collaboration |
2007-05 | PHASE2 |
| NCT02015728 | UNKNOWN | Recurrent Childhood Brain Tumor |
Seattle Children's Hospital |
2013-12 | |
| NCT01771458 | COMPLETED | Reccurent/Metastatic Solid Tumor Disease |
Institut Curie |
2012-10 | PHASE2 |
| NCT00777036 | COMPLETED | Leukemia |
Bristol-Myers Squibb |
2009-03-20 | PHASE2 |
| NCT00550615 | COMPLETED | Non-Hodgkin's Lymphoma |
University of Nebraska |
2007-09-17 | PHASE1; PHASE2 |
| NCT01441882 | COMPLETED | Refractory Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia |
OHSU Knight Cancer Institute |
2011-10 | PHASE2 |
| NCT01844765 | COMPLETED | Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia |
Novartis Pharmaceuticals |
2013-08-20 | PHASE2 |
| NCT00792948 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Adult L1 Acute Lymphoblastic Leukemia; Adult L2 Acute Lymphoblastic Leukemia; Adult T Acute Lymphoblastic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2009-09-01 | PHASE2 |
| NCT02047149 | TERMINATED | Chronic Myelogenous Leukemia |
University of Massachusetts, Worcester |
2014-01 | PHASE1 |
| NCT01643278 | COMPLETED | Gastrointestinal Stromal Tumor; Stage III Soft Tissue Sarcoma; Stage IV Soft Tissue Sarcoma |
National Cancer Institute (NCI) |
2012-07 | PHASE1 |
| NCT00700882 | COMPLETED | Melanoma (Skin) |
Eastern Cooperative Oncology Group |
2009-07-02 | PHASE2 |
| NCT01725204 | COMPLETED | Leukemia, Myeloid, Chronic-Phase |
Norwegian University of Science and Technology |
2012-09 | PHASE2 |
| NCT01685125 | UNKNOWN | Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate Cancer |
University of Southern California |
2012-09 | PHASE2 |
| NCT00882583 | TERMINATED | Head and Neck Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2009-07 | PHASE1 |
| NCT00892190 | COMPLETED | Acute Myelogenous Leukemia; Myelodysplastic Syndrome |
University of Pittsburgh |
2011-04 | PHASE1 |
| NCT01488318 | TERMINATED | Squamous Cell Carcinoma Of The Head And Neck |
Julie E. Bauman, MD, MPH |
2011-09 | PHASE2 |
| NCT01357655 | TERMINATED | Leukemia |
Bristol-Myers Squibb |
2011-09 | PHASE2 |
| NCT01440998 | COMPLETED | Endometrial Adenocarcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Mucinous Adenocarcinoma; Endometrial Serous Adenocarcinoma; Endometrial Squamous Cell Carcinoma; Endometrial Transitional Cell Carcinoma; Endometrial Undifferentiated Carcinoma; Endometrioid Adenocarcinoma; Recurrent Uterine Corpus Carcinoma; Stage III Uterine Corpus Cancer AJCC v7; Stage IIIA Uterine Corpus Cancer AJCC v7; Stage IIIB Uterine Corpus Cancer AJCC v7; Stage IIIC Uterine Corpus Cancer AJCC v7; Stage IV Uterine Corpus Cancer AJCC v7; Stage IVA Uterine Corpus Cancer AJCC v7; Stage IVB Uterine Corpus Cancer AJCC v7 |
National Cancer Institute (NCI) |
2011-09-20 | PHASE1 |
| NCT00850382 | COMPLETED | Acute Myeloid Leukemia (AML) |
University of Ulm |
2009-06 | PHASE1; PHASE2 |
| NCT01660906 | COMPLETED | Chronic Phase Chronic Myeloid Leukemia |
Bristol-Myers Squibb |
2012-12 | PHASE4 |
| NCT01310010 | COMPLETED | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive |
Grupo Espanol de trasplantes hematopoyeticos y terapia celular |
2010-04 | PHASE2 |
| NCT01724879 | COMPLETED | Philadelphia Positive Acute Lymphoblastic Leukemia |
Goethe University |
2011-11 | PHASE2 |
| NCT01077544 | COMPLETED | Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia |
Novartis Pharmaceuticals |
2011-04-14 | PHASE1 |
| NCT00895128 | COMPLETED | Advanced Cancer |
M.D. Anderson Cancer Center |
2009-04 | PHASE1 |
| NCT00903734 | COMPLETED | Advanced Cancers |
M.D. Anderson Cancer Center |
2009-04 | PHASE1 |
| NCT01802450 | UNKNOWN | Chronic Myeloid Leukemia |
PETHEMA Foundation |
2013-03 | PHASE2 |
| NCT01482728 | COMPLETED | Endometrial Cancer |
University of Virginia |
2012-01 | EARLY_PHASE1 |
| NCT01173679 | TERMINATED | Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma |
Massachusetts General Hospital |
2010-07 | PHASE2 |
| NCT00720109 | COMPLETED | Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 |
National Cancer Institute (NCI) |
2008-07-14 | PHASE2; PHASE3 |
| NCT00662636 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Mayo Clinic |
2008-08 | PHASE1 |
| NCT00982488 | COMPLETED | Leukemia |
Bristol-Myers Squibb |
2007-10 | PHASE2 |
| NCT00892177 | COMPLETED | Glioblastoma Multiforme |
Alliance for Clinical Trials in Oncology |
2009-10 | PHASE2 |
| NCT00869401 | COMPLETED | Brain and Central Nervous System Tumors |
Alliance for Clinical Trials in Oncology |
2009-06 | PHASE1; PHASE2 |
| NCT02129166 | WITHDRAWN | Healthy Volunteers |
University of Florida |
2014-09 | PHASE1 |
| NCT01092728 | TERMINATED | Melanoma |
M.D. Anderson Cancer Center |
2011-03 | PHASE2 |
| NCT00608361 | COMPLETED | Adult Acute Lymphoblastic Leukemia in Remission; Adult B Acute Lymphoblastic Leukemia; Adult Hepatocellular Carcinoma; Adult Nasal Type Extranodal NK/T-Cell Lymphoma; Adult Solid Neoplasm; Adult T Acute Lymphoblastic Leukemia; Advanced Adult Hepatocellular Carcinoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-Cell Lymphoma; Chronic Lymphocytic Leukemia; Cutaneous B-Cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Hepatosplenic T-Cell Lymphoma; Intraocular Lymphoma; Localized Non-Resectable Adult Liver Carcinoma; Localized Resectable Adult Liver Carcinoma; Lymphomatous Involvement of Non-Cutaneous Extranodal Site; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Nodal Marginal Zone Lymphoma; Progressive Hairy Cell Leukemia Initial Treatment; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Lymphoma; Recurrent Adult Liver Carcinoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-Cell Leukemia/Lymphoma; Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Small Intestinal Lymphoma; Splenic Marginal Zone Lymphoma; Stage II Small Lymphocytic Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-Cell Leukemia/Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IIIA Mycosis Fungoides and Sezary Syndrome; Stage IIIB Mycosis Fungoides and Sezary Syndrome; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-Cell Leukemia/Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Stage IVA Mycosis Fungoides and Sezary Syndrome; Stage IVB Mycosis Fungoides and Sezary Syndrome; T-Cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Hairy Cell Leukemia; Waldenstrom Macroglobulinemia |
National Cancer Institute (NCI) |
2008-10 | PHASE1 |
| NCT01514864 | TERMINATED | Carcinoma, Non-small Cell Lung |
Bristol-Myers Squibb |
2012-05-31 | PHASE2 |
| NCT00036738 | COMPLETED | Adult Acute Lymphoblastic Leukemia in Remission; Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blastic Phase; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase of Disease; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Disease |
Fred Hutchinson Cancer Center |
2001-07-13 | PHASE2 |
| NCT00696072 | COMPLETED | Metastatic Breast Cancer |
Bristol-Myers Squibb |
2008-08 | PHASE2 |
| NCT00826449 | COMPLETED | Lung Cancer; Non-Small Cell Lung Cancer |
M.D. Anderson Cancer Center |
2009-02 | PHASE1; PHASE2 |
| NCT00936975 | COMPLETED | Hormone-Resistant Prostate Cancer; Metastatic Malignant Neoplasm in the Bone; Recurrent Prostate Carcinoma; Stage IV Prostate Cancer |
National Cancer Institute (NCI) |
2009-09 | PHASE2 |
| NCT00780676 | TERMINATED | Breast Cancer |
M.D. Anderson Cancer Center |
2009-06 | PHASE2 |
| NCT01004497 | COMPLETED | Acute Lymphoblastic Leukemia |
The Catholic University of Korea |
2010-03 | PHASE2 |
| NCT00940524 | COMPLETED | Leukemia; Acute Lymphoblastic Leukemia |
Memorial Sloan Kettering Cancer Center |
2009-07 | PHASE1 |
| NCT00779389 | COMPLETED | Head and Neck Cancer; Non Small Cell Lung Cancer |
University of Pittsburgh |
2009-01 | PHASE1 |
| NCT01398046 | COMPLETED | Healthy |
University of California, San Francisco |
2011-08 | PHASE1 |
| NCT01916785 | COMPLETED | Chronic Myelogenous Leukemia, BCR/ABL Positive |
Versailles Hospital |
2009-05 | PHASE2 |
| NCT01306942 | COMPLETED | Metastatic Breast Cancer |
Spanish Breast Cancer Research Group |
2011-07 | PHASE1; PHASE2 |
| NCT00924352 | COMPLETED | Metastatic Breast Cancer |
Accelerated Community Oncology Research Network |
2009-06 | PHASE1; PHASE2 |
| NCT01395017 | COMPLETED | Pancreatic Cancer |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2011-06 | PHASE2 |
| NCT00895960 | TERMINATED | Glioblastoma; CNS Disease; Brain Diseases |
M.D. Anderson Cancer Center |
2009-05-07 | PHASE1 |
| NCT01238211 | COMPLETED | Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1; Core Binding Factor Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia |
National Cancer Institute (NCI) |
2010-12-14 | PHASE2 |
| NCT00787267 | TERMINATED | Non Small Cell Lung Cancer |
Duke University |
2008-09 | PHASE2 |
| NCT00903006 | TERMINATED | Breast Cancer |
M.D. Anderson Cancer Center |
2009-11 | PHASE1; PHASE2 |
| NCT01218477 | COMPLETED | Leukemia |
Bristol-Myers Squibb |
2011-01 | PHASE1; PHASE2 |
| NCT01826838 | WITHDRAWN | Prostate Cancer |
Brown University |
2013-01 | PHASE1 |
| NCT01342679 | COMPLETED | Chronic Myeloid Leukemia |
Kanto CML Study Group |
2011-04 | PHASE2 |
| NCT00429234 | COMPLETED | Advanced Cancer; Solid Tumors |
M.D. Anderson Cancer Center |
2007-01 | PHASE1 |
| NCT01169753 | TERMINATED | Chronic Myeloid Leukemia |
M.D. Anderson Cancer Center |
2011-05 | |
| NCT00859937 | COMPLETED | Malignant Salivary Gland Neoplasm; Recurrent Salivary Gland Carcinoma; Salivary Gland Adenoid Cystic Carcinoma; Stage IV Major Salivary Gland Cancer AJCC v7 |
National Cancer Institute (NCI) |
2009-03-16 | PHASE2 |
| NCT00474812 | COMPLETED | Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage IV Pancreatic Cancer |
National Cancer Institute (NCI) |
2007-05 | PHASE2 |
| NCT00410813 | COMPLETED | Breast Cancer; Metastatic Cancer |
SWOG Cancer Research Network |
2007-03 | PHASE2 |
| NCT01260688 | COMPLETED | Hormone Refractory Prostate Cancer; Recurrent Prostate Cancer |
National Cancer Institute (NCI) |
2010-10 | PHASE2 |
| NCT01051115 | UNKNOWN | Chronic Lymphocytic Leukemia |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2008-10 | PHASE2 |
| NCT01491633 | TERMINATED | Squamous Cell Lung Cancer |
Dana-Farber Cancer Institute |
2011-09 | PHASE2 |
| NCT01887561 | UNKNOWN | Myelogenous Leukemia, Chronic, Chronic Phase |
Kanto CML Study Group |
2012-11 | PHASE2 |
| NCT00706641 | COMPLETED | Transitional Cell Carcinoma of the Bladder |
Hoosier Cancer Research Network |
2008-06 | |
| NCT00364286 | COMPLETED | Leukemia; Lymphoma |
M.D. Anderson Cancer Center |
2006-08 | PHASE2 |
| NCT00544908 | TERMINATED | Pancreatic Cancer |
City of Hope Medical Center |
2007-09 | PHASE2 |
| NCT00452673 | COMPLETED | Advanced Breast Cancer |
Bristol-Myers Squibb |
2007-06 | PHASE1 |
| NCT00495872 | COMPLETED | Solid Tumors |
M.D. Anderson Cancer Center |
2007-06 | PHASE1 |
| NCT01602952 | COMPLETED | Leukemia; Leukemia, Myeloid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Philadelphia Chromosome; Hematologic Diseases |
Il-Yang Pharm. Co., Ltd. |
2008-07 | PHASE1; PHASE2 |
| NCT00744497 | COMPLETED | Prostatic Neoplasms |
Bristol-Myers Squibb |
2008-10 | PHASE3 |
| NCT01426334 | TERMINATED | Accelerated Phase Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia |
National Cancer Institute (NCI) |
2011-09 | PHASE1 |
| NCT00866736 | COMPLETED | Chronic Myeloid Leukemia |
Kanto CML Study Group |
2009-03 | PHASE2 |
| NCT00624585 | COMPLETED | Myelodysplastic Syndromes |
H. Lee Moffitt Cancer Center and Research Institute |
2008-02 | |
| NCT02113319 | COMPLETED | Acute Myelogenous Leukemia |
University Hospital, Angers |
2007-04 | PHASE2 |
| NCT00459342 | COMPLETED | Non-small Cell Lung Cancer; Recurrent Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer |
National Cancer Institute (NCI) |
2007-03 | PHASE2 |
| NCT00563290 | COMPLETED | Recurrent Skin Cancer; Squamous Cell Carcinoma of the Skin; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia |
National Cancer Institute (NCI) |
2007-11 | PHASE2 |
| NCT00949988 | TERMINATED | Chronic Lymphocytic Leukemia |
University of California, San Diego |
2009-05 | PHASE1; PHASE2 |
| NCT00996723 | COMPLETED | Diffuse Intrinsic Pontine Glioma |
St. Jude Children's Research Hospital |
2009-10 | PHASE1 |
| NCT00439270 | COMPLETED | Metastatic Prostate Cancer |
Bristol-Myers Squibb |
2007-07 | PHASE1; PHASE2 |
| NCT00570700 | COMPLETED | Hormone-refractory Prostate Cancer; Adenocarcinoma of the Prostate; Hormone-resistant Prostate Cancer; Prostate Cancer; Recurrent Prostate Cancer |
University of California, Irvine |
2007-07 | PHASE2 |
| NCT00918385 | TERMINATED | Prostate Cancer |
Duke University |
2009-05 | PHASE2 |
| NCT00568750 | COMPLETED | Gastrointestinal Stromal Tumor |
Swiss Cancer Institute |
2008-01-22 | PHASE2 |
| NCT00979160 | UNKNOWN | Systemic Mastocytosis |
Federico II University |
2009-11 | PHASE2 |
| NCT00872976 | WITHDRAWN | Chronic Lymphocytic Leukemia |
Bristol-Myers Squibb |
2009-05 | PHASE1 |
| NCT00754325 | COMPLETED | Advanced Breast Cancer |
Bristol-Myers Squibb |
2008-09 | PHASE2 |
| NCT00895297 | TERMINATED | Chronic Myeloid Leukemia |
European Society for Blood and Marrow Transplantation |
2010-02 | PHASE2 |
| NCT00560391 | COMPLETED | Multiple Myeloma |
Bristol-Myers Squibb |
2008-05 | PHASE1 |
| NCT00672295 | COMPLETED | Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer |
AA Secord |
2007-08 | PHASE1 |
| NCT00597038 | COMPLETED | Metastatic Melanoma |
H. Lee Moffitt Cancer Center and Research Institute |
2007-11 | PHASE1; PHASE2 |
| NCT01392703 | COMPLETED | Pharmacokinetic Study in Healthy Participants |
Bristol-Myers Squibb |
2011-07 | PHASE1 |
| NCT00570401 | COMPLETED | Lung Cancer |
Memorial Sloan Kettering Cancer Center |
2006-06 | PHASE2 |
| NCT00504153 | COMPLETED | Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer |
National Cancer Institute (NCI) |
2007-07 | PHASE2 |
| NCT00816283 | COMPLETED | Leukemia |
City of Hope Medical Center |
2008-09 | PHASE1 |
| NCT00306202 | COMPLETED | Leukemia |
Bristol-Myers Squibb |
2006-03-31 | PHASE1 |
| NCT00948389 | TERMINATED | Glioblastoma |
Bristol-Myers Squibb |
2009-10 | PHASE1; PHASE2 |
| NCT01116128 | TERMINATED | Myeloma |
Fondazione EMN Italy Onlus |
2008-02 | PHASE2 |
| NCT00717704 | COMPLETED | Solid Tumor |
Medstar Health Research Institute |
2008-07 | PHASE1 |
| NCT00546104 | COMPLETED | Advanced Breast Cancer |
Duke University |
2007-10 | PHASE2 |
| NCT02888990 | COMPLETED | Leukemia, Lymphoblastic, Acute |
Versailles Hospital |
2007-08 | PHASE2 |
| NCT00459108 | TERMINATED | Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Recurrent Adult Primary Liver Cancer |
National Cancer Institute (NCI) |
2007-04 | PHASE2 |
| NCT00423735 | COMPLETED | Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Recurrent Adult Brain Neoplasm |
National Cancer Institute (NCI) |
2007-01-24 | PHASE2 |
| NCT00787852 | TERMINATED | Non-Small Cell Lung Cancer |
Brown University |
2009-03 | PHASE1 |
| NCT00767520 | COMPLETED | Breast Cancer |
Bristol-Myers Squibb |
2009-02 | PHASE2 |
| NCT00817531 | TERMINATED | Breast Cancer |
Baylor Breast Care Center |
2008-12 | PHASE2 |
| NCT00732186 | WITHDRAWN | Leukemia, Myeloid, Chronic |
Bristol-Myers Squibb |
2009-08 | PHASE1 |
| NCT00835679 | TERMINATED | Liver Metastases; Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Signet Ring Adenocarcinoma of the Colon; Signet Ring Adenocarcinoma of the Rectum; Stage IV Colon Cancer; Stage IV Rectal Cancer |
National Cancer Institute (NCI) |
2009-12 | EARLY_PHASE1 |
| NCT00560352 | TERMINATED | Multiple Myeloma |
Bristol-Myers Squibb |
2008-02 | PHASE1 |
| NCT00852566 | COMPLETED | Chronic Myeloid Leukemia |
Norwegian University of Science and Technology |
2009-03 | PHASE2 |
| NCT00918463 | TERMINATED | Diffuse Large B-cell Lymphoma |
Weill Medical College of Cornell University |
2009-06 | PHASE2 |
| NCT00860158 | TERMINATED | Prostate Cancer |
Noah Hahn, M.D. |
2009-03 | PHASE2 |
| NCT00671788 | COMPLETED | Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma |
Gynecologic Oncology Group |
2008-06 | PHASE2 |
| NCT00070499 | ACTIVE_NOT_RECRUITING | Chronic Myeloid Leukemia, BCR-ABL1 Positive |
National Cancer Institute (NCI) |
2004-08-15 | PHASE2 |
| NCT00438854 | COMPLETED | Chronic Lymphocytic Leukemia |
Massachusetts General Hospital |
2006-12 | PHASE2 |
| NCT00538980 | TERMINATED | Polycythemia Vera |
Weill Medical College of Cornell University |
2007-04-30 | PHASE2 |
| NCT00444015 | COMPLETED | Non-Small-Cell Lung Carcinoma |
H. Lee Moffitt Cancer Center and Research Institute |
2007-03 | PHASE1 |
| NCT00609999 | COMPLETED | Glioblastoma; Gliosarcoma |
Duke University |
2008-01 | PHASE1 |
| NCT00345826 | COMPLETED | Leukemia |
Jonsson Comprehensive Cancer Center |
2005-11 | PHASE1 |
| NCT00858403 | TERMINATED | Lung Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
2009-03 | PHASE2 |
| NCT00764309 | COMPLETED | Scleroderma |
Bristol-Myers Squibb |
2009-01 | PHASE1; PHASE2 |
| NCT00598091 | TERMINATED | Refractory Solid Tumors; Pancreatic Adenocarcinoma |
Duke University |
2007-04 | PHASE1 |
| NCT00734864 | WITHDRAWN | Glioblastoma Multiforme; Gliosarcoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Glioma |
Annick Desjardins |
2009-06 | PHASE1 |
| NCT00920868 | COMPLETED | Solid Tumor; Metastatic Colorectal Cancer |
Herbert Hurwitz, MD |
2009-05 | PHASE1 |
| NCT00788125 | TERMINATED | Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Liver Cancer; Lymphoma; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell Tumor; Unspecified Childhood Solid Tumor, Protocol Specific |
City of Hope Medical Center |
2008-09-03 | PHASE1; PHASE2 |
| NCT00436605 | COMPLETED | Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV Melanoma |
National Cancer Institute (NCI) |
2006-12 | PHASE2 |
| NCT00509041 | COMPLETED | Malignant Mesothelioma |
Alliance for Clinical Trials in Oncology |
2007-08 | PHASE2 |
| NCT00507767 | COMPLETED | Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Nasopharynx; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Salivary Gland Squamous Cell Carcinoma; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Nasopharynx; Stage IVA Salivary Gland Cancer; Stage IVA Squamous Cell Carcinoma of the Larynx; Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVA Squamous Cell Carcinoma of the Oropharynx; Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IVA Verrucous Carcinoma of the Larynx; Stage IVA Verrucous Carcinoma of the Oral Cavity; Stage IVB Salivary Gland Cancer; Stage IVB Squamous Cell Carcinoma of the Larynx; Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVB Squamous Cell Carcinoma of the Oropharynx; Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IVB Verrucous Carcinoma of the Larynx; Stage IVB Verrucous Carcinoma of the Oral Cavity; Stage IVC Salivary Gland Cancer; Stage IVC Squamous Cell Carcinoma of the Larynx; Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVC Squamous Cell Carcinoma of the Oropharynx; Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IVC Verrucous Carcinoma of the Larynx; Stage IVC Verrucous Carcinoma of the Oral Cavity; Tongue Cancer |
National Cancer Institute (NCI) |
2007-07 | PHASE2 |
| NCT00320190 | TERMINATED | Leukemia, Myeloid, Chronic |
Bristol-Myers Squibb |
2006-08 | PHASE2 |
| NCT00481247 | COMPLETED | Myeloid Leukemia, Chronic |
Bristol-Myers Squibb |
2007-09 | PHASE3 |
| NCT00829647 | WITHDRAWN | Chronic Lymphocytic Leukemia; Leukemia |
Scripps Health |
2009-01 | PHASE1; PHASE2 |
| NCT00316953 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Childhood Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Meningeal Chronic Myelogenous Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Relapsing Chronic Myelogenous Leukemia; Unspecified Childhood Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2006-03 | PHASE1 |
| NCT00564876 | TERMINATED | Carcinoma, Non-Small-Cell Lung |
Duke University |
2007-11 | PHASE2 |
| NCT00388427 | COMPLETED | Malignant Solid Tumour |
University of Pittsburgh |
2007-06 | PHASE1 |
| NCT00529763 | COMPLETED | Leukemia |
Bristol-Myers Squibb |
2007-11-17 | PHASE2 |
| NCT01030718 | COMPLETED | Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia |
Bristol-Myers Squibb |
2006-01 | PHASE1; PHASE2 |
| NCT00482703 | COMPLETED | Myeloid Leukemia, Chronic |
Bristol-Myers Squibb |
2007-05 | PHASE1; PHASE2 |
| NCT00371345 | COMPLETED | Breast Cancer; Metastasis |
Bristol-Myers Squibb |
2006-12 | PHASE2 |
| NCT00470054 | COMPLETED | Extensive Stage Small Cell Lung Cancer; Limited Stage Small Cell Lung Cancer; Recurrent Small Cell Lung Cancer |
National Cancer Institute (NCI) |
2007-04 | PHASE2 |
| NCT00385580 | COMPLETED | Prostate Cancer |
Bristol-Myers Squibb |
2007-01 | PHASE2 |
| NCT00978731 | COMPLETED | Leukemia |
Bristol-Myers Squibb |
2005-12 | PHASE1 |
| NCT00339144 | COMPLETED | Tumors |
Bristol-Myers Squibb |
2007-01 | PHASE1 |
| NCT00391989 | COMPLETED | Lymphoblastic Leukemia, Acute |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2006-09 | PHASE2 |
| NCT00371254 | COMPLETED | Breast Cancer; Metastasis |
Bristol-Myers Squibb |
2006-12 | PHASE2 |
| NCT00362466 | TERMINATED | Leukemia |
Bristol-Myers Squibb |
2007-04 | PHASE3 |
| NCT00655746 | COMPLETED | Healthy |
Bristol-Myers Squibb |
2008-04 | PHASE1 |
| NCT00429949 | COMPLETED | Relapsed, Refractory or Plateau Phase Multiple Myeloma |
Washington University School of Medicine |
2007-01 | PHASE2 |
| NCT00101595 | COMPLETED | Chronic Myeloid Leukemia; Leukemia, Lymphoblastic, Acute, Philadelphia-positive |
Bristol-Myers Squibb |
2005-01 | PHASE2 |
| NCT00500006 | TERMINATED | Chronic Myelogenous Leukemia; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive |
Merck Sharp & Dohme LLC |
2007-10 | PHASE1 |
| NCT00099606 | COMPLETED | Neoplasms |
Bristol-Myers Squibb |
2004-07 | PHASE1 |
| NCT00298987 | COMPLETED | Leukemia, Myeloid, Chronic; Leukemia, Lymphocytic, Acute, L2 |
Bristol-Myers Squibb |
2006-02 | PHASE2 |
| NCT00162214 | TERMINATED | Tumors |
Bristol-Myers Squibb |
2005-08 | PHASE1 |
| NCT00337454 | COMPLETED | Chronic Myelogenous Leukemia |
Bristol-Myers Squibb |
2005-07 | PHASE1; PHASE2 |
| NCT00324077 | WITHDRAWN | Myeloid Leukemia, Chronic, Chronic-Phase |
Bristol-Myers Squibb |
2006-08 | PHASE1 |
| NCT00349518 | WITHDRAWN | Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia |
Bristol-Myers Squibb |
2006-12 | PHASE2; PHASE3 |
| NCT00123487 | COMPLETED | Myeloid Leukemia, Chronic, Accelerated Phase; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive |
Bristol-Myers Squibb |
2005-06 | PHASE3 |
| NCT00064233 | COMPLETED | Leukemia |
Jonsson Comprehensive Cancer Center |
2003-11 | PHASE1 |
| NCT00101660 | COMPLETED | Chronic Myeloid Leukemia; Philadelphia-Positive Myeloid Leukemia |
Bristol-Myers Squibb |
2005-02 | PHASE2 |
| NCT00123474 | COMPLETED | Myeloid Leukemia, Chronic, Chronic-Phase |
Bristol-Myers Squibb |
2005-07 | PHASE3 |
| NCT00101647 | COMPLETED | Chronic Myelogenous Leukemia |
Bristol-Myers Squibb |
2004-12 | PHASE2 |
| NCT00103844 | COMPLETED | Chronic Myeloid Leukemia; Philadelphia-Positive Myeloid Leukemia |
Bristol-Myers Squibb |
2005-02 | PHASE2 |
| NCT00101816 | COMPLETED | Chronic Myeloid Leukemia; Blast Crisis |
Bristol-Myers Squibb |
2004-12 | PHASE2 |
| NCT00103701 | COMPLETED | Leukemia, Myeloid, Chronic-phase; Leukemia, Lymphoblastic, Acute, Philadelphia-positive |
Bristol-Myers Squibb |
2003-11 | PHASE1 |
| NCT01410708 | WITHDRAWN | Breast Cancer |
AHS Cancer Control Alberta |
PHASE2 | |
| NCT00112775 | UNKNOWN | Leukemia |
Jonsson Comprehensive Cancer Center |
2005-03 | PHASE2 |
(data from https://clinicaltrials.gov, updated on 2026-08-19)
Check the
Dasatinib (BMS-354825)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Dasatinib (BMS-354825) Mechanism of Action: Src Kinase Inhibition in Senescent Cells Research
- Dasatinib (BMS-354825): Selectivity & Specificity
- Dasatinib (BMS-354825) Working Concentration | Cell Culture | Treatment
- Dasatinib (BMS-354825) Solubility in DMSO
- Dasatinib (BMS-354825) Stock Solution
- Dasatinib (BMS-354825) Storage
- Dasatinib (BMS-354825) Stability
- Dasatinib (BMS-354825) Combination Database
- Dasatinib (BMS-354825) Molecular Weight
- Dasatinib (BMS-354825) SMILES
- Dasatinib (BMS-354825) CAS Number
- Dasatinib (BMS-354825) Chemical Structure (2D and 3D)
- Dasatinib (BMS-354825) IC50 for Cell-based and Cell-free Assays
- Dasatinib (BMS-354825) MedChemExpress (HY-10181)? Try a better option.
- Dasatinib (BMS-354825) Cayman (11498)? Try a better option.
- Dasatinib (BMS-354825) Sigma (SML2589)? Try a better option.
- Dasatinib (BMS-354825) Abmole (M1701)? Try a better option.
- Dasatinib (BMS-354825) Tocris (6793)? Try a better option.
- Dasatinib (BMS-354825) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.